Business Context and Reporting Period
This Form 8-K was filed by Gevo, Inc. on August 14, 2020, reporting an event that occurred on August 12, 2020. The Company is a Delaware corporation with its principal executive offices in Englewood, Colorado, and its common stock trades on the Nasdaq Capital Market under the symbol "GEVO."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance metrics.
Material Changes
On August 12, 2020, Gevo, Inc. received notification from Nasdaq staff that the closing bid price of its common stock had been below the $1.00 per share minimum requirement for 30 consecutive business days. This constitutes a failure to satisfy Nasdaq Listing Rule 5550(a)(2). There is no immediate effect on the listing status, and trading continues under the symbol "GEVO."
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has an initial 180-calendar-day period, ending February 8, 2021, to regain compliance.
- Compliance Requirement: To regain compliance, the closing bid price must be $1.00 or more for at least 10 consecutive business days before the February 8, 2021 deadline.
- Contingency Plans: If compliance is not met by the deadline, the Company may be eligible for an additional 180-day period if it meets other listing standards (excluding bid price) and provides written notice of intent to cure, potentially via a reverse stock split.
- Risks: There is no assurance the Company will regain compliance or avoid delisting. If the Company fails to cure the deficiency or is deemed ineligible for an extension, Nasdaq may initiate delisting proceedings. The Company may appeal such a determination, but approval is not guaranteed.
Investor Verification Checklist
- Verify the current closing bid price of GEVO stock relative to the $1.00 threshold.
- Monitor the Company's progress toward achieving 10 consecutive days of compliance before February 8, 2021.
- Review future filings for announcements regarding a potential reverse stock split or extension requests.
- Check for any subsequent Nasdaq notifications regarding delisting or appeal outcomes.